Gilead to present 29 abstracts on liver disease treatments at EASL 2026

May 13, 2026 8:30 AM

Gilead Sciences Inc. (NASDAQ: GILD) announced it will present findings from 29 abstracts at the European Association for the Study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found